Listing ID #7025951
Company Information
Ask for more detail from the seller
Contact SupplierComposition :
Docosahexaenoic acid 120 MG+Eicosapentaenoic acid (EPA) 180 MG+Elemental chromium 100 MCG+Elemental copper 2 MG+Elemental manganese 4 MG+Elemental selenium 40 MCG+Elemental zinc 14 MG+ Elemental Magnesium 40mg+ Folic acid 300 MCG+Pyridoxine 2 MG+Vitamin A 2500 IU+Vitamin C 50 MG+Vitamin E 10 MG
Indication :
Manage stress, fatigue & weakness in patients with cardio daibetic disorder, chronic fatigue syndrome & Menopausal transition
Lords Mark Biotech was established in the year 2022 in Mumbai, Maharashtra, India. We are exporters and traders of Taspro protein powder, pharmaceutical injections, syrup and a lot more. As we work more which systemizes our approach towards innovation, however, we realize that understanding customer needs is what distinguishes us from other technological organizations.
Our commitment is to implement a quality management system to sustain a culture of operational excellence. Lords Mark Biotech is committed to delivering affordable and high-quality products, a fundamental element of our company’s mission and vision.
Lords Mark Biotech is trusted by healthcare professionals across the country.
Quality Products
We follow a strict quality policy with the best product at an economical price.
A Dynamic Product Basket
Empowered by a passionate production team, Lords Mark Biotech has one of the strongest product portfolios.
Ensuring Product Safety and Efficacy
Our patient-centric approach extends to our quality policy as well. Our focus on quality helps us to ensure product safety and efficacy, regardless of the drug form. We believe that quality is the mainstay of competitiveness and create an environment of Quality and Compliance, in line with global best practices.
Our dedication to quality in everything we do is uncompromising and covers every stage of the development, production, and marketing of our medicines.
Our commitment is to implement a robust global quality management system to sustain a culture of operational excellence, while meeting and exceeding the expectations of all stakeholders, including patients, customers and regulators.